Safety of ultrasound-guided botulinum toxin type A injections for patients with anticoagulant and antiplatelet background medication

2019 ◽  
Vol 20 (2) ◽  
pp. 66-69
Author(s):  
Marius-Nicolae Popescu ◽  
◽  
Luminiţa Dumitru ◽  
Matei Teodorescu ◽  
Alina Iliescu ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Ultrasound Guided

scholarly journals Ultrasound guided injections of botulinum toxin type A into stellate ganglion to treat insomnia

2017 ◽  
Vol 14 (2) ◽  
pp. 1136-1140
Author(s):  
Xu-Dong Ding ◽  
Zhi-Gang Ding ◽  
Wei Wang ◽  
Yan-Ping Liu ◽  
Jing Zhong ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Stellate Ganglion ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Ultrasound Guided

scholarly journals Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain

Toxins ◽  
2016 ◽  
Vol 8 (1) ◽  
pp. 18 ◽  
Author(s):  
Young Moon ◽  
Jung Choi ◽  
Hue Park ◽  
Ji Park ◽  
Ji Kim
Keyword(s):  
Neuropathic Pain ◽  
Botulinum Toxin ◽  
Nerve Block ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Ultrasound Guided

scholarly journals Ultrasound-guided five-point injection of botulinum toxin for patients with trapezius hypertrophy

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Wanying Chen ◽  
Xiaoyu Zhang ◽  
Yingying Xu ◽  
Zemin Xu ◽  
Haiyan Qin ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Trapezius Muscle ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Therapeutic Effects ◽  
Ultrasound Guided ◽  
Compound Muscle Action Potentials ◽  
Point Injection ◽  
Appearance Changes

Abstract Objectives Our study aimed to explore the clinical therapeutic effects of ultrasound-guided five-point injection of botulinum toxin type A for patients with trapezius hypertrophy. Methods Twenty female patients diagnosed with trapezius hypertrophy were enrolled in this study. The thicknesses of the trapezius muscle were measured by using the ultrasound scanner to locate the thickest point of trapezius, followed by labelling the other four points around the first point. Botulinum toxin type A was injected bilaterally (50 IU/side, 5 points/side) in the trapezius muscle of these patients. The surgery effects were evaluated by thicknesses of the trapezius muscle, intramuscular needle electromyographic and electroneurographic examinations, appearance changes and patients’ satisfactions. Results Statistically significant differences in thicknesses of the trapezius muscle were observed at 4 weeks (p < 0.001), 12 weeks (p < 0.001), 20 weeks (p < 0.001), 28 weeks (p = 0.011), 36 weeks (p = 0.022), and 44 weeks (p = 0.032) after surgery. The latencies of trapezius muscle became longer at 12 weeks after surgery (left: 2.40 ms, right: 2.53 ms vs. left: 1.75 ms, right: 2.00 ms). Electroneurographic results showed amplitude reduction of compound muscle action potentials (CMAPs) at 12 weeks after surgery (left: 1.91 uV, right: 3.10 uV vs. left: 15.00 uV, right: 15.40 uV). Obvious appearance changes were revealed at 12 weeks after surgery. All of 80% patients were very satisfied, 15% patients were relatively satisfied, and 5% patients were not satisfied with the surgery. Conclusion Ultrasound-guided five-point injection of botulinum toxin type A might be effective for patients with trapezius hypertrophy.

Sign in / Sign up

Export Citation Format

Share Document